TOPICAL FORMULATION OF AN ANTICHOLINERGIC COMPOUND FOR TREATING SEVERE HYPERHIDROSIS AND EXCESSIVE SWEATING

The present invention relates to a topical formulation comprising at least one anticholinergic compound for use in treating patients suffering from severe hyperhidrosis, wherein administration of the formulation to the patient comprises: a) an initial phase with a topical administration of a predetermined amount of the formulation 5 to 7 times per week for a total time period of less than six months; followed by b) a maintenance phase with a topical administration of the same amount of the formulation 1 to less than 5 times per week..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 13. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

DR MASUR CLARISSA [VerfasserIn]
DR SCHULZE ZUR WIESCHE ERIK [VerfasserIn]
DR NEUHAUS BERNHARD [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-13, Last update posted on www.tib.eu: 2024-03-26, Last updated: 2024-03-29

Patentnummer:

EP4333831

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA001389017